Obesity Featured Articles

  1. India Opens The Fast Lane For Drug Development 4/15/2026

    New in 2026, extensive reforms to India’s clinical trial rules are slashing approval timelines in half and eliminating licenses that once took months to obtain.

  2. U.S. Pharma Tariffs And MFN Become Law After April 2 Update 4/15/2026

    Beginning July 31, 2026, a U.S. pharmaceutical tariff will apply to patented products and their APIs, beginning with large companies. Beroe Inc.'s Mathini Ilancheran breaks down the tariff's impact, explores its risks, and proposes five procurement strategies to addressing them.

  3. Clinical Trials Succeed When Patients Talk — And The Entire Ecosystem Listens 4/15/2026

    Patient advocate and founder of MIB Agents Ann Graham knows intimately the importance of including patient feedback into trial design. She explains value of — and offers practical advice — for doing just that.

  4. How Sponsors Can Ensure Their Sites Are Aligned With ICH E6 R3 4/14/2026

    Updated GCP expectations reshape sponsor–site collaboration. Clear guidance on systems, data governance, and monitoring reduces risk, strengthens oversight, and supports compliance with ICH E6(R3).

  5. What Really Moves The Needle In Primary Immunodeficiency Research And Treatment 4/14/2026

    Kedrion Biopharma's Nisha Jain details how researchers can improve trials for primary immunodeficiency and shares four factors for improvement.

  6. Clinical Trials Have A Native American Problem 4/14/2026

    Kelsey Powell is working to close a long-standing gap in clinical trials: the lack of participation from Native American communities. Her experience highlights how issues of trust, awareness, and fragmented systems continue to limit access — and what it will take to change that.

  7. When Clinical Trials Span Borders, Participants Shouldn't Cross Alone 4/13/2026

    Discover how human-centered support reduces barriers in global research. By prioritizing empathy and logistics, you can improve the participant experience and boost study outcomes.

  8. First-In-Human Porcine Kidney Transplant Trial Builds On Expanded Access Success 4/13/2026

    eGenesis CEO Mike Curtis discusses the first-in-human trial of EGEN-2784, which they're studying whether a porcine kidney can restore near-normal quality of life while awaiting a human transplant.

  9. RBQM And Centralized Monitoring Need Action 4/10/2026

    After COVID forced sponsors to move faster than ever, many are now confronting a harder challenge: ownership. Marci Thear explains why RBQM and centralized monitoring only work when sponsors move beyond reviewing outputs and start acting on the signals.

  10. Assigned Slot Allocation Offers A Fair Solution For Oncology Phase 1 Trials (Part 2) 4/10/2026

    In part two of this series on slot allocation, Nehal Lakhani, MD, Ph.D. proposes assigned slot allocation as an alternative to competitive placement and discusses how the approach might benefit patients and sites.